This compound is a chiral cyclopentene carboxylic acid derivative containing a chlorinated purine ring. It is recognized as a process-related impurity formed during the synthesis of the pharmaceutical intermediate abacavir.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-(4-ethylphenyl)-2-methylpropanoic acid
pharmaceutical intermediate
5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole
pharmaceutical intermediate
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole
pharmaceutical intermediate
2-[4-[(2-butyl-4-chloro-5-formylimidazol-1-yl)methyl]phenyl]benzonitrile
pharmaceutical intermediate
(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol
pharmaceutical intermediate
(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
pharmaceutical intermediate
Descyclopropyl abacavir
pharmaceutical raw material
6-Ethoxy Abacavir
pharmaceutical intermediate
(1S,4R)-4-(2-amino-6-chloropurin-9-yl)cyclopent-2-ene-1-carboxylic acid
DDZCJFRPQWAWFC-RITPCOANSA-N
C1[C@@H](C=C[C@@H]1N2C=NC3=C2N=C(N=C3Cl)N)C(=O)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.